Clinical Trial Update: Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing aliskiren/HCTZ to ramipril in obese patients with stage 2 hypertension has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren HCTZ (aliskiren with hydrochlorothiazide)
• Ramipril (ramipril)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-03-02